Form 4: UnitedHealth Group Director McNabb Acquires Deferred Stock Units

Director Frederick William McNabb III acquired 194 deferred stock units of UnitedHealth Group on July 1, 2024, as part of his quarterly compensation for board service.

Summary

• On July 1, 2024, Frederick William McNabb III, a director of UnitedHealth Group, acquired 194 shares of common stock in the form of deferred stock units.
• These units were granted as regular quarterly compensation for his service as a director.
• The price per share was $0.
• Following the transaction, McNabb directly owns 13,034 shares of UnitedHealth Group common stock.
• These deferred stock units are immediately vested but must be retained until McNabb completes his service on the Board.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The alignment of director interests with shareholders is a positive aspect.

Positives

• The acquisition of deferred stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment to the company.

Industry Context

Director compensation in the form of stock options and deferred stock units is a common practice among publicly traded companies to align the interests of board members with those of shareholders.

Comparison to Industry Standards

• Companies like CVS Health (CVS) and Anthem (now Elevance Health, ELV) also utilize stock-based compensation for their directors.
• The specific amount and vesting terms can vary based on company size, performance, and industry practices.
• Benchmarking against peer companies would provide a more detailed assessment of the appropriateness of the compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.

Key Dates